Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Denorex “Deep Down Dandruff Relief” Ads Debuting In November

This article was originally published in The Tan Sheet

Executive Summary

Medtech Products will launch a multi-million-dollar ad campaign in November to reacquaint dandruff sufferers with Denorex medicated shampoos and conditioners

You may also be interested in...



Wyeth OTC Loratadine Launch Unaffected By ANDA Exclusivity Issues – Exec

Wyeth Consumer Healthcare, which reported sluggish third quarter sales, could experience a big revenue boost late in Q4 if its plans to launch OTC loratadine upon expiration of Schering-Plough's patent remain on track

Wyeth OTC Loratadine Launch Unaffected By ANDA Exclusivity Issues – Exec

Wyeth Consumer Healthcare, which reported sluggish third quarter sales, could experience a big revenue boost late in Q4 if its plans to launch OTC loratadine upon expiration of Schering-Plough's patent remain on track

Wyeth OTC Loratadine Launch Unaffected By ANDA Exclusivity Issues – Exec

Wyeth Consumer Healthcare, which reported sluggish third quarter sales, could experience a big revenue boost late in Q4 if its plans to launch OTC loratadine upon expiration of Schering-Plough's patent remain on track

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094701

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel